[{"address1": "16 Abba Hillel Road", "city": "Ramat Gan", "zip": "5250608", "country": "Israel", "phone": "972 3 693 8448", "fax": "972 3 693 8447", "website": "https://galmedpharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Galmed Pharmaceuticals Ltd., a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule which is in Phase III study for oral treatment for non-alcoholic steato-hepatitis (NASH) in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The company also evaluates Aramchol through ARRIVE Study, a Phase IIa clinical trial with HIV-associated non-alcoholic fatty liver disease and lipodystrophy. In addition, it engages in the development of Amilo-5MER, a 5 amino acid synthetic peptide methionine, threonine, alanine, aspartic acid, and valine. Further, the company develops MyBiotics which is in pre-clinical trials for NASH and fibrosis. It has a license agreement with Samil Pharma. Co., Ltd. for the commercialization of Aramchol in the Republic of Korea; and a collaboration agreement with OnKai for its AI platform. Galmed Pharmaceuticals Ltd. was founded in 2000 and is headquartered in Ramat Gan, Israel.", "fullTimeEmployees": 3, "companyOfficers": [{"maxAge": 1, "name": "Mr. Allen  Baharaff", "age": 59, "title": "Co-Founder, President, CEO & Chairman", "yearBorn": 1965, "fiscalYear": 2024, "totalPay": 1467116, "exercisedValue": 0, "unexercisedValue": 4940}, {"maxAge": 1, "name": "Mr. Doron  Cohen", "age": 57, "title": "Chief Financial Officer", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 252093, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Guy  Nehemya", "age": 39, "title": "COO & Data Protection Officer", "yearBorn": 1985, "fiscalYear": 2024, "totalPay": 294347, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Yohai  Stenzler CPA", "age": 41, "title": "Chief Accounting Officer", "yearBorn": 1983, "fiscalYear": 2024, "totalPay": 298107, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Liat  Hayardeny MBA, Ph.D.", "age": 57, "title": "Chief Scientific Officer", "yearBorn": 1967, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Tali  Gorfine", "age": 54, "title": "Medical Consultant", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 202763, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.9238, "open": 0.89, "dayLow": 0.884, "dayHigh": 0.946, "regularMarketPreviousClose": 0.9238, "regularMarketOpen": 0.89, "regularMarketDayLow": 0.884, "regularMarketDayHigh": 0.946, "payoutRatio": 0.0, "forwardPE": -0.9125243, "volume": 64950, "regularMarketVolume": 64950, "averageVolume": 2072719, "averageVolume10days": 12445160, "averageDailyVolume10Day": 12445160, "bid": 0.6519, "ask": 1.15, "bidSize": 2, "askSize": 2, "marketCap": 5149930, "fiftyTwoWeekLow": 0.745, "fiftyTwoWeekHigh": 3.61, "allTimeHigh": 4870.8, "allTimeLow": 0.745, "fiftyDayAverage": 1.31006, "twoHundredDayAverage": 1.585255, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -13918699, "profitMargins": 0.0, "floatShares": 5385067, "sharesOutstanding": 5479231, "sharesShort": 1321, "sharesShortPriorMonth": 19221, "sharesShortPreviousMonthDate": 1760486400, "dateShortInterest": 1763078400, "sharesPercentSharesOut": 0.0002, "heldPercentInsiders": 0.00915, "heldPercentInstitutions": 0.01043, "shortRatio": 0.02, "shortPercentOfFloat": 0.0002, "impliedSharesOutstanding": 5479232, "bookValue": 3.488, "priceToBook": 0.26946676, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -8700000, "trailingEps": -5.61, "forwardEps": -1.03, "lastSplitFactor": "1:12", "lastSplitDate": 1724976000, "enterpriseToEbitda": 1.974, "52WeekChange": -0.68571424, "SandP52WeekChange": 0.1265819, "quoteType": "EQUITY", "currentPrice": 0.9399, "recommendationMean": 3.0, "recommendationKey": "hold", "totalCash": 19051000, "totalCashPerShare": 3.489, "ebitda": -7049750, "totalDebt": 0, "quickRatio": 7.929, "currentRatio": 7.979, "returnOnAssets": -0.20900999, "returnOnEquity": -0.46341, "freeCashflow": -4465250, "operatingCashflow": -6339000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "GLMD", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1764366461, "regularMarketTime": 1764363600, "exchange": "NCM", "messageBoardId": "finmb_114779940", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "shortName": "Galmed Pharmaceuticals Ltd.", "longName": "Galmed Pharmaceuticals Ltd.", "regularMarketChangePercent": 1.7428004, "regularMarketPrice": 0.9399, "fiftyDayAverageChange": -0.37016004, "fiftyDayAverageChangePercent": -0.28255197, "twoHundredDayAverageChange": -0.64535505, "twoHundredDayAverageChangePercent": -0.40709856, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "3.0 - Hold", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1394717400000, "postMarketChangePercent": -3.1811848, "postMarketPrice": 0.91, "postMarketChange": -0.029899955, "regularMarketChange": 0.01609999, "regularMarketDayRange": "0.884 - 0.946", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 2072719, "fiftyTwoWeekLowChange": 0.19489998, "fiftyTwoWeekLowChangePercent": 0.26161072, "fiftyTwoWeekRange": "0.745 - 3.61", "fiftyTwoWeekHighChange": -2.6701, "fiftyTwoWeekHighChangePercent": -0.7396399, "fiftyTwoWeekChangePercent": -68.57143, "earningsTimestampStart": 1756238400, "earningsTimestampEnd": 1756756800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -5.61, "epsForward": -1.03, "displayName": "Galmed Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-11-29"}]